IL2 and neoplasm: Given that CEACAM1 expression on both immune cells and tumor cells is reported to be upregulated following activation by IL-2 or tumor cell contact [30, 31], we also investigated whether anti-PD-1 treatment enhances CEACAM1 expression on CD8+ T cells.